A citation-based method for searching scientific literature

B Oppmann, R Lesley, B Blom, J C Timans, Y Xu, B Hunte, F Vega, N Yu, J Wang, K Singh, F Zonin, E Vaisberg, T Churakova, M Liu, D Gorman, J Wagner, S Zurawski, Y Liu, J S Abrams, K W Moore, D Rennick, R de Waal-Malefyt, C Hannum, J F Bazan, R A Kastelein. Immunity 2000
Times Cited: 2047







List of co-cited articles
1007 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R.
Christi Parham, Madaline Chirica, Jacqueline Timans, Elena Vaisberg, Marilyn Travis, Jeanne Cheung, Stefan Pflanz, Rebecca Zhang, Komal P Singh, Felix Vega,[...]. J Immunol 2002
965
28

Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain.
Daniel J Cua, Jonathan Sherlock, Yi Chen, Craig A Murphy, Barbara Joyce, Brian Seymour, Linda Lucian, Wayne To, Sylvia Kwan, Tatyana Churakova,[...]. Nature 2003
27

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation.
Claire L Langrish, Yi Chen, Wendy M Blumenschein, Jeanine Mattson, Beth Basham, Jonathan D Sedgwick, Terrill McClanahan, Robert A Kastelein, Daniel J Cua. J Exp Med 2005
24

IL-12 family cytokines: immunological playmakers.
Dario A A Vignali, Vijay K Kuchroo. Nat Immunol 2012
745
19

The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing.
Sarah L Gaffen, Renu Jain, Abhishek V Garg, Daniel J Cua. Nat Rev Immunol 2014
925
18

IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases.
Michele W L Teng, Edward P Bowman, Joshua J McElwee, Mark J Smyth, Jean-Laurent Casanova, Andrea M Cooper, Daniel J Cua. Nat Med 2015
455
16

Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17.
Sudeepta Aggarwal, Nico Ghilardi, Ming-Hong Xie, Frederic J de Sauvage, Austin L Gurney. J Biol Chem 2003
16

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.
Laurie E Harrington, Robin D Hatton, Paul R Mangan, Henrietta Turner, Theresa L Murphy, Kenneth M Murphy, Casey T Weaver. Nat Immunol 2005
15

Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease.
Brian G Feagan, William J Sandborn, Christopher Gasink, Douglas Jacobstein, Yinghua Lang, Joshua R Friedman, Marion A Blank, Jewel Johanns, Long-Long Gao, Ye Miao,[...]. N Engl J Med 2016
850
13

IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4-CD8- entheseal resident T cells.
Jonathan P Sherlock, Barbara Joyce-Shaikh, Scott P Turner, Cheng-Chi Chao, Manjiri Sathe, Jeff Grein, Daniel M Gorman, Edward P Bowman, Terrill K McClanahan, Jennifer H Yearley,[...]. Nat Med 2012
690
13

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.
Estelle Bettelli, Yijun Carrier, Wenda Gao, Thomas Korn, Terry B Strom, Mohamed Oukka, Howard L Weiner, Vijay K Kuchroo. Nature 2006
13

Transforming growth factor-beta induces development of the T(H)17 lineage.
Paul R Mangan, Laurie E Harrington, Darrell B O'Quinn, Whitney S Helms, Daniel C Bullard, Charles O Elson, Robin D Hatton, Sharon M Wahl, Trenton R Schoeb, Casey T Weaver. Nature 2006
12

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.
Ivaylo I Ivanov, Brent S McKenzie, Liang Zhou, Carlos E Tadokoro, Alice Lepelley, Juan J Lafaille, Daniel J Cua, Dan R Littman. Cell 2006
12

Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study.
Brian G Feagan, William J Sandborn, Geert D'Haens, Julián Panés, Arthur Kaser, Marc Ferrante, Edouard Louis, Denis Franchimont, Olivier Dewit, Ursula Seidler,[...]. Lancet 2017
259
12

Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn's Disease: A Phase 2a Study.
Bruce E Sands, Jingjing Chen, Brian G Feagan, Mark Penney, William A Rees, Silvio Danese, Peter D R Higgins, Paul Newbold, Raffaella Faggioni, Kaushik Patra,[...]. Gastroenterology 2017
157
11

Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation.
Craig A Murphy, Claire L Langrish, Yi Chen, Wendy Blumenschein, Terrill McClanahan, Robert A Kastelein, Jonathon D Sedgwick, Daniel J Cua. J Exp Med 2003
10

Cutting edge: IL-23 receptor gfp reporter mice reveal distinct populations of IL-17-producing cells.
Amit Awasthi, Lorena Riol-Blanco, Anneli Jäger, Thomas Korn, Caroline Pot, George Galileos, Estelle Bettelli, Vijay K Kuchroo, Mohamed Oukka. J Immunol 2009
274
10

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.
Marc Veldhoen, Richard J Hocking, Christopher J Atkins, Richard M Locksley, Brigitta Stockinger. Immunity 2006
10

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.
Bruce E Sands, William J Sandborn, Remo Panaccione, Christopher D O'Brien, Hongyan Zhang, Jewel Johanns, Omoniyi J Adedokun, Katherine Li, Laurent Peyrin-Biroulet, Gert Van Assche,[...]. N Engl J Med 2019
362
10

Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides.
Spencer C Liang, Xiang-Yang Tan, Deborah P Luxenberg, Riyez Karim, Kyriaki Dunussi-Joannopoulos, Mary Collins, Lynette A Fouser. J Exp Med 2006
9

TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology.
Mandy J McGeachy, Kristian S Bak-Jensen, Yi Chen, Cristina M Tato, Wendy Blumenschein, Terrill McClanahan, Daniel J Cua. Nat Immunol 2007
9

The inhibitory cytokine IL-35 contributes to regulatory T-cell function.
Lauren W Collison, Creg J Workman, Timothy T Kuo, Kelli Boyd, Yao Wang, Kate M Vignali, Richard Cross, David Sehy, Richard S Blumberg, Dario A A Vignali. Nature 2007
9



Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis.
Kim A Papp, Andrew Blauvelt, Michael Bukhalo, Melinda Gooderham, James G Krueger, Jean-Philippe Lacour, Alan Menter, Sandra Philipp, Howard Sofen, Stephen Tyring,[...]. N Engl J Med 2017
288
8

Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity.
Caroline E Sutton, Stephen J Lalor, Cheryl M Sweeney, Corinna F Brereton, Ed C Lavelle, Kingston H G Mills. Immunity 2009
8

Generation of pathogenic T(H)17 cells in the absence of TGF-β signalling.
Kamran Ghoreschi, Arian Laurence, Xiang-Ping Yang, Cristina M Tato, Mandy J McGeachy, Joanne E Konkel, Haydeé L Ramos, Lai Wei, Todd S Davidson, Nicolas Bouladoux,[...]. Nature 2010
993
8

Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial.
Wolfgang Hueber, Bruce E Sands, Steve Lewitzky, Marc Vandemeulebroecke, Walter Reinisch, Peter D R Higgins, Jan Wehkamp, Brian G Feagan, Michael D Yao, Marek Karczewski,[...]. Gut 2012
958
8

IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways.
Liang Zhou, Ivaylo I Ivanov, Rosanne Spolski, Roy Min, Kevin Shenderov, Takeshi Egawa, David E Levy, Warren J Leonard, Dan R Littman. Nat Immunol 2007
8

The composition and signaling of the IL-35 receptor are unconventional.
Lauren W Collison, Greg M Delgoffe, Clifford S Guy, Kate M Vignali, Vandana Chaturvedi, DeLisa Fairweather, Abhay R Satoskar, K Christopher Garcia, Christopher A Hunter, Charles G Drake,[...]. Nat Immunol 2012
297
8

Structural Activation of Pro-inflammatory Human Cytokine IL-23 by Cognate IL-23 Receptor Enables Recruitment of the Shared Receptor IL-12Rβ1.
Yehudi Bloch, Laura Bouchareychas, Romain Merceron, Katarzyna Składanowska, Lien Van den Bossche, Sammy Detry, Srinath Govindarajan, Dirk Elewaut, Filomeen Haerynck, Melissa Dullaers,[...]. Immunity 2018
71
11

Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.
M Kobayashi, L Fitz, M Ryan, R M Hewick, S C Clark, S Chan, R Loudon, F Sherman, B Perussia, G Trinchieri. J Exp Med 1989
8

Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial.
Atul Deodhar, Philip S Helliwell, Wolf-Henning Boehncke, Alexa P Kollmeier, Elizabeth C Hsia, Ramanand A Subramanian, Xie L Xu, Shihong Sheng, Prasheen Agarwal, Bei Zhou,[...]. Lancet 2020
91
8

Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris.
Edmund Lee, William L Trepicchio, Judith L Oestreicher, Debra Pittman, Frank Wang, Francesca Chamian, Madhav Dhodapkar, James G Krueger. J Exp Med 2004
660
8

Development, cytokine profile and function of human interleukin 17-producing helper T cells.
Nicholas J Wilson, Katia Boniface, Jason R Chan, Brent S McKenzie, Wendy M Blumenschein, Jeanine D Mattson, Beth Basham, Kathleen Smith, Taiying Chen, Franck Morel,[...]. Nat Immunol 2007
7

Ustekinumab induction and maintenance therapy in refractory Crohn's disease.
William J Sandborn, Christopher Gasink, Long-Long Gao, Marion A Blank, Jewel Johanns, Cynthia Guzzo, Bruce E Sands, Stephen B Hanauer, Stephan Targan, Paul Rutgeerts,[...]. N Engl J Med 2012
739
7


Integrative responses to IL-17 and TNF-α in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis.
Andrea Chiricozzi, Emma Guttman-Yassky, Mayte Suárez-Fariñas, Kristine E Nograles, Suyan Tian, Irma Cardinale, Sergio Chimenti, James G Krueger. J Invest Dermatol 2011
404
7

Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials.
Kenneth B Gordon, Bruce Strober, Mark Lebwohl, Matthias Augustin, Andrew Blauvelt, Yves Poulin, Kim A Papp, Howard Sofen, Lluís Puig, Peter Foley,[...]. Lancet 2018
264
7


A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17.
Heon Park, Zhaoxia Li, Xuexian O Yang, Seon Hee Chang, Roza Nurieva, Yi-Hong Wang, Ying Wang, Leroy Hood, Zhou Zhu, Qiang Tian,[...]. Nat Immunol 2005
7


STAT3 and NF-kappaB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice.
Mi-La Cho, Jung-Won Kang, Young-Mee Moon, Hyo-Jung Nam, Joo-Yeon Jhun, Seong-Beom Heo, Hyun-Tak Jin, So-Youn Min, Ji-Hyeon Ju, Kyung-Su Park,[...]. J Immunol 2006
249
7

Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion.
Aleksandra V Rachitskaya, Anna M Hansen, Reiko Horai, Zhuqing Li, Rafael Villasmil, Dror Luger, Robert B Nussenblatt, Rachel R Caspi. J Immunol 2008
313
7

STAT3 regulates cytokine-mediated generation of inflammatory helper T cells.
Xuexian O Yang, Athanasia D Panopoulos, Roza Nurieva, Seon Hee Chang, Demin Wang, Stephanie S Watowich, Chen Dong. J Biol Chem 2007
7

Essential autocrine regulation by IL-21 in the generation of inflammatory T cells.
Roza Nurieva, Xuexian O Yang, Gustavo Martinez, Yongliang Zhang, Athanasia D Panopoulos, Li Ma, Kimberly Schluns, Qiang Tian, Stephanie S Watowich, Anton M Jetten,[...]. Nature 2007
7

IL-17 and Th17 Cells.
Thomas Korn, Estelle Bettelli, Mohamed Oukka, Vijay K Kuchroo. Annu Rev Immunol 2009
7

IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells.
Stefan Pflanz, Jackie C Timans, Jeanne Cheung, Rency Rosales, Holger Kanzler, Jonathan Gilbert, Linda Hibbert, Tatyana Churakova, Marilyn Travis, Elena Vaisberg,[...]. Immunity 2002
7

A novel IL-23p19/Ebi3 (IL-39) cytokine mediates inflammation in Lupus-like mice.
Xiaoqian Wang, Yinxiang Wei, He Xiao, Xiaoling Liu, Yu Zhang, Gencheng Han, Guojiang Chen, Chunmei Hou, Ning Ma, Beifen Shen,[...]. Eur J Immunol 2016
94
7

Induction and molecular signature of pathogenic TH17 cells.
Youjin Lee, Amit Awasthi, Nir Yosef, Francisco J Quintana, Sheng Xiao, Anneli Peters, Chuan Wu, Markus Kleinewietfeld, Sharon Kunder, David A Hafler,[...]. Nat Immunol 2012
726
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.